SFX by Ex Libris Inc.

Title:	Cleavage of amyloid beta peptide during constitutive processing of its precursor
Source:	Science [0036-8075] Esch, F S yr:1990

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	HAASS, C. "AMYLOID BETA-PEPTIDE IS PRODUCED BY CULTURED-CELLS DURING NORMAL METABOLISM." Nature 359.6393 (1992): 322-325.
description	2.	Sisodia, S S S. "Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing." Science 248.4954 (1990): 492-5.
description	3.	Shoji, M. "Production of the Alzheimer amyloid beta protein by normal proteolytic processing." Science 258.5079 (1992): 126-9.
description	4.	De Strooper, B.. "Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein." Nature 391.6665 (1998): 387-390.
description	5.	Small, D H H. "The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?" Neurochemical Research 23.5 (1998): 795-806.
description	6.	Seubert, C. "Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids." Nature 359.6393 (1992): 325-7.
description	7.	Hsiao, G. "Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice." Science 274.5284 (1996): 99-102.
description	8.	Hardy, J. "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics." Science 297.5580 (2002): 353-6.
description	9.	De Strooper, B. "A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain." Nature 398.6727 (1999): 518-522.
description	10.	Selkoe, Dennis J J. "Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics." Annual review of pharmacology and toxicology 43.1 (2003): 545-584.
description	11.	Selkoe, D J J. "Alzheimer's disease: genes, proteins, and therapy." Physiological reviews 81.2 (2001): 741-66.
description	12.	Grimm, M. "Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin." Nature cell biology 7.11 (2005): 1118-23.
description	13.	Kamenetz, F. "APP processing and synaptic function." Neuron 37.6 (2003): 925-937.
description	14.	Walsh, D M M. "The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain." Biochemistry 39.35 (2000): 10831-10839.
description	15.	Schenk, D. "Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse." Nature 400.6740 (1999): 173-7.
description	16.	JARRETT, P T T. "THE CARBOXY TERMINUS OF THE BETA-AMYLOID PROTEIN IS CRITICAL FOR THE SEEDING OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE." Biochemistry 32.18 (1993): 4693-4697.
description	17.	Dobson, Christopher M M. "Protein folding and misfolding." Nature 426.6968 (2003): 884-890.
description	18.	Blennow, K. "Alzheimer's disease." The lancet 368.9533 (2006): 387-403.
description	19.	Goedert, M. "Tau protein and neurodegeneration." Seminars in cell & developmental biology 15.1 (2004): 45-9.
description	20.	Masliah, E. "Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease." Laboratory investigation 77.3 (1997): 197-209.